Murmakki (Commiphora myrrha): An Integrative Review of Unani Medicine, Phytochemistry and Pharmacological Evidence

Background: Murmakki, commonly known as myrrh and botanically identified as Commiphora myrrha (T.Nees) Engl., is an important oleo-gum-resin used in Unani medicine for various inflammatory, infectious, gastrointestinal, respiratory, wound-related and gynaecological conditions. Despite its longstanding traditional use, the available evidence remains scattered across classical literature and modern scientific studies. Objective: This review aims to provide an integrative and critical overview of Murmakki, with particular emphasis on its Unani traditional concepts, botanical and pharmacognostic characteristics, phytochemical constituents, pharmacological activities, clinical evidence, safety, and quality-control considerations. Methods: Relevant literature was reviewed from classical Unani texts, pharmacognostic references, and scientific databases including PubMed/MEDLINE, Scopus, ScienceDirect, and Google Scholar. Published literature concerning Commiphora myrrha, Murmakki, myrrh, phytochemistry, pharmacology, clinical studies, safety, and Unani medicinal applications was evaluated and organised according to the level of available evidence. Results: C. myrrha contains diverse phytoconstituents, particularly terpenoids and characteristic furanosesquiterpenes. Experimental studies have reported anti-inflammatory, analgesic, antimicrobial, antioxidant, antidiabetic, neuroprotective, cytotoxic and gastroprotective activities. These findings provide varying degrees of preclinical support for several traditional applications. However, clinical evidence remains limited, and differences in botanical source, chemical composition, extraction methods, and standardization affect reproducibility and interpretation. Conclusion: Murmakki demonstrates considerable pharmacological potential; however, most evidence remains preclinical. Proper botanical authentication, chemical standardization, detailed safety evaluation, and well-designed clinical trials are required to establish its efficacy, safety, dosage, and therapeutic relevance. Keywords: Murmakki; Commiphora myrrha; Myrrh; Unani medicine; oleo-gum-resin; Phytochemistry; Pharmacology

Authors

Publication Details

Journal
Journal of Drug Delivery and Therapeutics
Published
2026-09-15
DOI
https://doi.org/10.22270/jddt.v16i9.8008
Primary Topic
Pharmacological Effects of Medicinal Plants
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Murmakki (Commiphora myrrha): An Integrative Review of Unani Medicine, Phytochemistry and Pharmacological Evidence

Ayesha Siddiqua, Shaik Adeena Parveen, Abdul Nasir Ansari, Khan Neha et al.
Journal of Drug Delivery and Therapeutics
Pharmacological Effects of Medicinal Plants
article

Murmakki (Commiphora myrrha): An Integrative Review of Unani Medicine, Phytochemistry and Pharmacological Evidence

Ayesha Siddiqua, Shaik Adeena Parveen, Abdul Nasir Ansari, Khan Neha, Usmani Misba Adam Ali, Abdul Azeez
article en

Abstract

Background: Murmakki, commonly known as myrrh and botanically identified as Commiphora myrrha (T.Nees) Engl., is an important oleo-gum-resin used in Unani medicine for various inflammatory, infectious, gastrointestinal, respiratory, wound-related and gynaecological conditions. Despite its longstanding traditional use, the available evidence remains scattered across classical literature and modern scientific studies. Objective: This review aims to provide an integrative and critical overview of Murmakki, with particular emphasis on its Unani traditional concepts, botanical and pharmacognostic characteristics, phytochemical constituents, pharmacological activities, clinical evidence, safety, and quality-control considerations. Methods: Relevant literature was reviewed from classical Unani texts, pharmacognostic references, and scientific databases including PubMed/MEDLINE, Scopus, ScienceDirect, and Google Scholar. Published literature concerning Commiphora myrrha, Murmakki, myrrh, phytochemistry, pharmacology, clinical studies, safety, and Unani medicinal applications was evaluated and organised according to the level of available evidence. Results: C. myrrha contains diverse phytoconstituents, particularly terpenoids and characteristic furanosesquiterpenes. Experimental studies have reported anti-inflammatory, analgesic, antimicrobial, antioxidant, antidiabetic, neuroprotective, cytotoxic and gastroprotective activities. These findings provide varying degrees of preclinical support for several traditional applications. However, clinical evidence remains limited, and differences in botanical source, chemical composition, extraction methods, and standardization affect reproducibility and interpretation. Conclusion: Murmakki demonstrates considerable pharmacological potential; however, most evidence remains preclinical. Proper botanical authentication, chemical standardization, detailed safety evaluation, and well-designed clinical trials are required to establish its efficacy, safety, dosage, and therapeutic relevance. Keywords: Murmakki; Commiphora myrrha; Myrrh; Unani medicine; oleo-gum-resin; Phytochemistry; Pharmacology

Journal of Drug Delivery and Therapeutics
Openalex Percentile: Top 12%
Pharmacological Effects of Medicinal Plants
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.